From Briefing.com: Tech stocks and the Nasdaq waded ahead as the session progressed, lifted by a strong Q3 performance by Texas Instruments (TXN 27.28 +1.61) and a technical rebound by biotech shares, many of which had fallen 3%-5% below their volatility bands. TXN's results and outlook helps to confirm that both a general economic as well as a tech recovery are resolutely underway. It is the latest addition to a daily stream of strong performance reports, beginning with Yahoo! (YHOO 42.82 +0.45; 10/08), followed by Intel (INTC 32.12 -0.04; 10/14), Novellus Systems (NVLS 39.49 +1.21; 10/14), Siebel Systems (SEBL 12.35 +0.31; 10/15), Nokia (NOK 17.19 +0.26; 10/16), Wipro (WIT 35.25 -0.46; 10/17) and culminating, until TXN, with Lexmark (LXK 74.22 +0.22; 10/21). These data points, in aggregate, provide a firmer base from which investors can effectively evaluate performance and valuations, and base market decisions. However, investors should not extrapolate these results to mean all companies will ride forward this wave of positive earnings. Economic recovery is a big Kahuna, but the tide of optimism that came in following aggressive fiscal and monetary policies to stimulate growth is fast dissipating, and the companies hanging ten are very much riding customized, motorized boards. With operating performance generally satisfactory, and valuations already riding the big Kahuna, we think the balance of October, like the first half, remains very much a traders' market. Keep an eye out for that wave.--Ping Yu, Briefing.com 6:20PM Tuesday After Hours price levels vs. 4pm ET: The after hours trade has a negative slant to it as traders have engaged in profit-taking activity. The catalyst has been a round of in-line financial outlooks from a number of companies whose stocks have enjoyed strong runs. Presently, the S&P futures, at 1044, are 1 point below fair value, and the Nasdaq 100 futures, at 1420, are 4 points below fair value.
To begin, Amazon.com (AMZN 58.06 -1.29) stock has traded 2% lower following the internet retailer's in line Q4 (Dec) and FY04 outlooks. After topping the Reuters Research top and bottom-line consensus estimates in its Q3 (Sept) report, the company said it expected Q4 (Dec) revenue growth of 23-34%, to $1.76-1.91 bln, which only encompassed the consensus expectation of $1.78 bln. Management did add, however, that it expects its biggest holiday shopping season ever thanks to free shipping and low prices. As for FY04, the company pegged net sales at $5.75-6.25 bln as compared to the consensus of $6.12 bln.
Amgen (AMGN 61.90 -1.75) shares have also fallen prey to profit-taking after the biotech company revised its FY03 (Dec) guidance. The company narrowed its total product sales range to $7.6-7.9 bln from $7.5-8.0 bln and total revenue range to $8.1-8.4 bln from $8.0-8.5 bln (consensus of $8.27 bln). Amgen also maintained its expectation for full-year EPS of $1.85-1.95. Nonetheless, traders have used the lack of upside guidance as an excuse to lighten positions from AMGN's 27% run year-to-date.
Other stocks have found a more favorable reception from traders tonight. Boston Scientific (00C 65.00 +1.16), for one, has advanced following its better than expected Q3 (Sept) report. The medical device company showed a 33% increase in EPS from year-ago levels, to $0.32 (consensus of $0.29), on revenues that rose 21% to record levels at $876.0 mln. Despite the fact that shares have received a 2% boost from the report, they are still 2% below the level we recommended investors exercise caution following the company's presentation of its Taxus IV data.
RF Micro Device (RFMD 11.85 +0.43) stock has also found considerable buying interest off its Q2 (Sept) report. The designer of proprietary radio frequency integrated circuits exceeded the Q2 (Sept) Reuters Research consensus forecast by $0.07, and reported revenue growth of 37% to $163.5 mln. Based on the current backlog, RF Micro Devices currently expects a double-digit sequential revenue increase to the low-$180 mln range in Q3 (Dec) and quarterly net income of $0.08-0.09 per share. Both forecasts are well above consensus estimates.
Finally, Career Education (CECO 47.75 +1.60) delivered its 23rd consecutive quarter of record breaking results in its Q3 (Sept) report. Revenues spiked 60%, to $197 mln, while EPS soared 73%, to $0.26 (consensus of $0.21). New student starts also rose 73%, to approximately 79,500, and supported a 58% increase in total student population. The post-secondary education provider also issued Q4 (Dec) and FY03 forecasts that surpassed the current consensus expectation. Related companies of CECO that have also received a bid are COCO and DV.
For complete coverage on these, and other developments, be sure to visit Briefing.com's In Play, Earnings Calendar, and Guidance pages. -- Heather Smith, Briefing.com
5:09PM MKS Instruments misses by a penny, ex items (MKSI) 22.46 +0.54: Reports Q3 (Sep) loss of $0.03 per share, ex items, $0.01 worse than the Reuters Research consensus of ($0.02); revenues fell 11.5% year/year to $81.6 mln vs the $82.0 mln consensus. Co. sees Q4 (Dec) revenues in the range of $85-89 mln, estimate is $88 mln and EPS of breakeven to a gain of $0.03, ex items, estimate is $0.04.
4:50PM TTM Tech beats by $0.02; guides up for Q4 (TTMI) 16.30 +0.27: Reports Q3 (Sep) earnings of $0.06 per share, $0.02 better than the Reuters Research consensus of $0.04; revenues rose 120.4% year/year to $45.3 mln vs the $44.9 mln consensus. Co. sees Q4 (Dec) EPS of $0.08-0.10, Reuters estimate is $0.07 and revenues in the range of $50-52 mln, estimate is $49 mln.
4:38PM California Micro to replace auditors (CAMD) 9.01 +0.31: Co announces that it will appoint a new audit firm before year end to replace Ernst and Young LLP, which recently has tendered its resignation. This resignation will become effective after Ernst and Young completes its review of the co's financial statements for Q2, which ended Sept 30, in connection with the Form 10-Q filing. Co confirmed that this development does not reflect any issues with respect to the accuracy or reliability of past financial statements or those it will file next month in its Form 10-Q, and also indicated that the Q2 financial results it will release on Oct 23 will be at or above the high end of its previous guidance.
4:31PM Cymer beats by $0.01, affirms Q4 (CYMI) 46.75 +1.82: Reports Q3 (Sep) loss of $(0.06) per share, ex-items, $0.01 better than the Reuters Research consensus of ($0.07); revenues fell 23.7% year/year to $64.4 mln vs the $64.1 mln consensus. Note: the co reported a loss of $(0.24), but we backed out a $15.6 mln write-off in tenant improvements. Co did not provide a per share after-tax impact for this write-off, so we extrapolated a $(0.06) loss using the stated tax rate of 40%... For Q4, co sees a 5%-10% sequential increase in sales which computes to $67.6-$70.8 mln vs R.R. consensus of $68.3 mln.
4:28PM Maxtor beats by $0.03, ex items (MXO) 15.30 +0.40: Reports Q3 (Sep) earnings of $0.20 per share, ex items, $0.03 better than the Reuters Research consensus of $0.17; revenues rose 30.0% year/year to $1.07 bln vs the $0.99 bln consensus.
4:22PM Storage Tech reports in line (STK) 26.61 +0.15: Reports Q3 (Sep) earnings of $0.28 per share, in line with the Reuters Research consensus of $0.28; revenues rose 3.7% year/year to $520.3 mln vs the $528.3 mln consensus.
4:21PM InVision beats by 3 cents, raises rev guidance above consensus (INVN) 25.60 -0.04: Reports Q3 (Sep) earnings of $0.50 per share, $0.03 better than the Reuters Research consensus of $0.47; revenues fell 26.5% year/year to $86.1 mln vs the $70.9 mln consensus. Co raises its 2003 rev guidance to $410 mln (consensus $403.5 mln), expects 2004 revs to be about $310 mln (consensus $277.4 mln), and expects sales to "resume growth" in 2005.
4:14PM RF Micro Device beats by $0.07, ex items, guides Q3 above consensus (RFMD) 11.38 +0.25: Reports Q2 (Sep) earnings of $0.07 per share, excluding ($0.01) charge, $0.07 better than the Reuters Research consensus of $0.00; revenues rose 36.6% year/year to $163.5 mln vs the $145.0 mln consensus. Co also guides Q3 (Dec), sees EPS of $0.08-0.09, vs the R.R. consensus of $0.03, and revenues in the "low-$180 mln range" vs an estimate of $156.9 mln.
4:10PM Amazon.com beats by a penny, ex items; guides for Q4 and Y04 revs (AMZN) 59.43 -0.16: Reports Q3 (Sep) earnings of $0.11 per share, ex items, $0.01 better than the Reuters Research consensus of $0.10; revenues rose 33.3% year/year to $1.13 bln vs the $1.12 bln consensus. Co. sees Q4 (Dec) revenues to be in the range of $1.76-1.91 bln and EPS and Y04 revenues of $5.75-6.25 bln, estimates are $1.78 bln and $6.12 bln, respectively.
4:08PM Amgen beats by $0.03, tightens Y03 rev guidance (AMGN) 63.65 +1.76: Reports Q3 (Sep) earnings of $0.53 per share, $0.03 better than the Reuters Research consensus of $0.50; revenues rose 47.2% year/year to $2.21 bln vs the $2.16 bln consensus. Company sees Y03 EPS of $1.85-1.95 vs consensus of $1.93 on revs of $8.1-8.4 bln, consensus is $8.27 bln and previous guidance of $8.0-8.5 bln.
4:08PM Pericom Semi reports in line, provides Q4 guidance (PSEM) 11.75 +1.26: Reports Q1 (Sep) loss of $0.03 per share, in line with the Reuters Research consensus of ($0.03); revenues rose 2.2% year/year to $11.1 mln vs the $10.8 mln consensus. The co is guiding Q2 revs in the $11.25-$11.75 mln range, which does include SaRonix. Pericom is anticipating SaRonix revs to be approximately $4.5 mln, which would put the low end of the range at $15.75 mln. Reuters Research currently estimates Q2 revs of $14.50 mln.
4:06PM Westell Tech beats by $0.01, guides DecQ revs slightly above consensus (WSTL) 8.97 +0.42: Reports Q2 (Sep) earnings of $0.07 per share, $0.01 better than the Reuters Research consensus of $0.06; revenues rose 3.9% year/year to $58.4 mln vs the $54.5 mln consensus. Co sees Q3 (Dec) sales of $58-$59 mln and EPS of $0.07 vs R.R. consensus of $54.7 mln and $0.07.
4:06PM Seagate Tech beats by 4 cents (STX) 29.50 +0.20: Reports Q1 (Sep) earnings of $0.40 per share, $0.04 better than the Reuters Research consensus of $0.36; revenues rose 10.2% year/year to $1.74 bln vs the $1.64 bln consensus.
4:05PM FSI Intl beats by $0.16, misses on revs (FSII) 6.24 -0.16: Reports Q4 (Aug) loss of $0.06 per share, $0.16 better than the Reuters Research consensus of ($0.22); revenues fell 26% year/year to $22.2 mln vs the $25.1 mln consensus.
Close Dow -30.30 at 9,747.64, S&P +1.34 at 1,046.03, Nasdaq +15.76 at 1,940.90: A decent day for the stock market even though the Dow was down and the S&P managed only a small gain...the Nasdaq posted yet another solid increase of 0.8%, the Russell 2000 small cap index was also up 0.8%, and advancers led decliners on both the NYSE and the Nasdaq...this was accomplished even though the earnings reports yesterday after the close and this morning were uninspiring except for a good report from Texas Instruments (TXN 27.28 +1.61)...SBC Communications (SBC 22.00 -0.40) and AT&T (T 20.00 -1.07) had mediocre reports as both posted declines in revenue from last year... DamilerChrysler (DCX 36.12 -1.18) reported earnings below expectations, while Wells Fargo (WFC 55.50 +0.13) missed by a penny...this set of data could easily have supplied journalists with headlines if the market had been broadly lower, but the resilience showed through again...there still appears to be plenty on investors looking to get in on any dips...after the close today the big reports are Amgen (AMGN 63.65 +1.76) and Amazon.com (AMZN 59.35 -0.24), but there are hundreds yet to come this week and next...the SOX semiconductor index was up 1.9%, while the bank index was down 0.3%.NYSE Adv/Dec 1734/1470, Nasdaq Adv/Dec 1850/1351
3:07PM Pericom Semi Earnings Preview (PSEM) 11.40 +0.90: Pericom Semiconductor reports its Q1 after the close with Reuters Research consensus earnings of ($0.03) and revs of $10.8 mln. JMP Securities recently recommended accumulating lagging mid-cap and small-cap names, citing Pericom specifically, stating its valuations are more attractive and its fundamentals in terms of revenue growth, margin expansion, and upside earnings revisions for CY04 and CY05, appear likely.
2:47PM Analog Devices estimates raised above consensus (ADI) 44.90 +1.88: Wedbush Morgan reiterates their Buy rating, raises their Q4 rev/EPS ests above consensus, and raises their target to $50 from $45; firm says evidence of a rising tide of demand has been evident from quarterly reports over the past 2 weeks, and they believe surprises are likely to be on the upside when the co reports its Q4 results on Nov 18.
2:45PM Maxtor Earnings Preview (MXO) 15.09 +0.19: Maxtor reports its Q3 after the close with Reuters Research consensus earnings of $0.17 per share and revs of $992.1 mln. Hoefer & Arnett has been speaking positively on the co given its recent note suggesting the next two quarters will be strong for the drive industry. Firm notes allocation is a distinct possibility and there is a growing belief we could see a PC upgrade cycle in 2004. The firm expects all three drive firms, which include MXO, STX and WDC to beat operating estimates for the Sept qtr. Hoefer & Arnett recently upped its 04 EPS estimate on MXO to $1.00 per share from $0.82 per share going into earnings.
1:55PM Genesis Microchip: Pacific Growth comments on court ruling (GNSS) 15.39 -0.64: -- Update -- Pacific Growth comments on news that an administrative law judge ruled that while GNSS has a valid patent, MRT & Trumpeon did not violate it. Firm says that ruling largely means that it's still business as usual for GNSS, and that there is no change to co's strong fundamentals.
biz.yahoo.com |